(AP) — The maker of the morning-after pill said it received assurances Tuesday that the government would quickly settle a three-year battle to sell the emergency contraceptive without a prescription to at least some women.
Last week, the Food and Drug Administration stunned Barr Pharmaceuticals Inc. by announcing that its long-delayed attempt was back on the table -- with some caveats.
The FDA said it would consider nonprescription sales of the pill, called Plan B, only for women 18 and older, and demanded details on how Woodcliff Lake, N.J.-based Barr would ensure that pharmacies enforced that age restriction.
After meeting with FDA officials Tuesday, Barr said it would amend its Plan B application within two weeks.
No comments:
Post a Comment